Delivery Order SPE2DB22D2211-SPE2DB25FSFLW
- Not listed
- The Defense Logistics Agency awarded a $17,412.86 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $16,681.52 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,664.06, for 180 tablets of Mesalamine 800 mg delayed-release formulation. This is a firm fixed price, non-set-aside contract awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a $6,571.87 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count supply) with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a ceiling value of $5,855.60. The contract, which employs firm fixed-price pricing, was competitively awarded without a set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine 800 mg delayed-release tablets (180-count quantity) under a firm fixed-price contract valued at $1,520.96. The award, issued on June 27, 2025, is a non-set-aside competitive delivery order with an ultimate completion date of June 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count) under a firm fixed-price contract. The order, valued at $40,028.47, is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a contract ceiling value of $2,854.12. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, representing a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The award carries no set-aside designation, indicating it was competitively awarded to the...
- The Defense Logistics Agency awarded a delivery order valued at $5,911.09 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on August 22, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a ceiling value of $8,263.21. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFLWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,163.06 to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication. The contract employs firm fixed-price pricing with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support globally. The IDC serves military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities with an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's competitive award history and experience as a major pharmaceutical distributor positions the company as a critical supplier within the federal medical supply chain, particularly for supporting military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/19/25 |